SEARCH

SEARCH BY CITATION

References

  • Aoki, N. & Yamanaka, T. (1978) The alpha 2-plasmin inhibitor levels in liver diseases. Clinica Chimica Acta, 84, 99105.
  • Aoki, N., Moroi, M., Matsuda, M., Tachiya, K. (1977) The behaviour of alpha 2-plasmin inhibitor in fibrinolytic states. Journal of Clinical Investigation, 60, 361369.
  • Aoki, N., Saito, H., Kamiya, T., Koie, K., Sakata, Y., Kobakura, M. (1979) Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency. Journal of Clinical Investigation, 63, 877884.
  • Aoki, N., Sakata, Y., Matsuda, M., Tateno, K. (1980) Fibrinolytic states in a patient with congenital deficiency of alpha 2-plasmin inhibitor. Blood, 55, 483488.
  • Aoki, N., Sakata, Y., Ichinose, A. (1983) Fibrin associated plasminogen activation in alpha 2-plasmin inhibitor deficiency. Blood, 62, 11181122.
  • Bangert, K., Johnsen, A.H., Christensen, U., Thorsen, S. (1993) Different N-terminal forms of alpha 2-plasmin-inhibitor in human plasma. Biochemical Journal, 291, 623625.
  • Christensen, S., Valnickova, Z., Thogersen, B., Olsen, E.H.N., Enghild, J.J. (1997) Assignment of a single disulphide bridge in human alpha 2-antiplasmin: implications for the structural and functional properties. Biochemical Journal, 323, 847852.
  • Chung, D.H., Ohashi, K., Watanabe, M., Miyasaka, N., Hirosawa, S. (2000) Mannose trimming targets mutant alpha 2-plasmin inhibitor for degradation by proteasome. Journal of Biological Chemistry, 275, 49814987.DOI: 10.1074/jbc.275.7.4981
  • Clemmensen, I., Thorsen, S., Mullertz, S., Petersen, L.C. (1981) Properties of three different molecular forms of the alpha 2-plasmin inhibitor. European Journal of Biochemistry, 120, 105112.
  • Collen, D. (1976) Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. European Journal of Biochemistry, 69, 209216.
  • Collen, D. & Wiman, B. (1979) Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma. Blood, 53, 313324.
  • Devaussuzenet, V., Ducou-le-Pointe, H., Doco, A.M., Mary, P.M., Montagne, J.P., Favier, R. (1998) A case of intramedullary haematoma associated with congenital alpha 2-plasmin inhibitor deficiency. Pediatrics Radiology, 28, 978980.
  • Favier, R., Richard, P., Maillet, J., Murat, I. (1997) Severe post adenoidectomy bleeding revealing congenital alpha 2-antiplasmin deficiency. Anesthesia and Analgesia, 84, 11471149.
  • Griffin, G.C., Mammen, E.F., Sokol, R.J., Perrotta, A.L., Stoyanovich, A., Abildgaard, C.F. (1993) Alpha2-antiplasmin deficiency. An overlooked cause of hemorrhage. The American Journal of Pediatric Hematology/Oncology, 15, 328330.
  • Guermazi, S., Khelif, A., Conard, J., Ennabli, S., Dellagi, K. (1997) Bleeding syndrome and isolated alpha 2-antiplasmin deficiency. Pathologie Biologie, 45, 483486.
  • Hirosawa, S., Nakamura, Y., Miura, O., Sumi, Y., Aoki, N. (1988) Organization of the human alpha 2-plasmin inhibitor gene. Proceedings of the National Academy of Sciences of the United States of America, 85, 68366840.
  • Holmes, W.E., Nelles, L., Lijnen, H.R., Collen, D. (1987a) Primary structure of human alpha 2-antiplasmin, a serine proteinase inhibitor (serpin). Journal of Biological Chemistry, 262, 16591664.
  • Holmes, W.E., Lijnen, H.R., Nelles, L., Kluft, C., Nieuwenhuis, H.K., Rijken, D.C., Collen, D. (1987b) Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity. Science, 238, 209211.
  • Ikematsu, S., Fukutake, K., Aoki, N. (1996) Heterozygote for plasmin inhibitor deficiency developing hemorrhagic tendency with advancing age. Thrombosis Research, 82, 129136.DOI: 10.1016/0049-3848(96)00059-x
  • Jansen, J.W., Haverkate, F., Koopman, J., Nieuwenhuis, H.K., Kluft, C., Boschman, T.A. (1987) Influence of factor XIIIa activity on human whole blood clot lysis in vitro. Thrombosis and Haemostasis, 57, 171175.
  • Kato, A., Hirosawa, S., Toyota, Y., Nakamura, Y., Nishi, H., Kimura, A., Sasazuki, T., Aoki, N. (1993) Localization of the human alpha 2-plasmin inhibitor gene (PLI) to 17p13. Cytogenetics and Cell Genetics, 62, 190191.
  • Kettle, P. & Mayne, E. (1985) A bleeding disorder due to deficiency of alpha 2-antiplasmin. Journal of Clinical Pathology, 38, 428429.
  • Kluft, C. & Los, N. (1981) Demonstration of two forms of α2 antiplasmin in plasma by modified crossed immuno-electrophoresis. Thrombosis Research, 21, 6571.
  • Kluft, C., Vellenga, E., Brommer, E.J.P., Wijngaards, G. (1982) A familial hemorrhagic diathesis in a dutch family: an inherited deficiency of α2-antiplasmin. Blood, 59, 11691180.
  • Kluft, C., Los, P., Jie, A.F.H., Van Hinsbergh, V.W.M., Vellenga, E., Jespersen, J., Henny, C.P. (1986) The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha 2-antiplasmin in blood. Blood, 67, 616622.
  • Kluft, C., Niewenhuis, H.K., Rijken, D.C., Groeneveld, E., Wijngaards, G., Van Berkel, W., Doijeward, G., Sixma, J.J. (1987) Alpha2-antiplasmin Enschede: dysfunctional alpha2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder. Journal of Clinical Investigation, 80, 13911400.
  • Knot, E.A.R., Ten Cate, J.W., Lamping, R.J., Liem, K.G. (1986) Alpha 2-antiplasmin functional characterization and metabolism in a heterozygote deficient patient. Thrombosis and Haemostasis, 55, 375378.
  • Koie, K., Ogata, K., Kamiya, T., Takamatsu, J., Kohakura, M. (1978) Alpha 2-plasmin-inhibitor deficiency (Miyasato disease). Lancet, 2, 13341336.
  • Kordich, L., Feldman, L., Porterie, P., Lago, O. (1985) Severe hemorragic tendency in heterozygous α2-antiplasmin deficiency. Thrombosis Research, 40, 645651.
  • Koyama, T., Koike, Y., Toyota, S., Miyagi, F., Suzuki, N., Aoki, N. (1994) Different NH2-terminal form with 12 additional residues of alpha 2-plasmin inhibitor from human and culture media of Hep G2 cells. Biochemical and Biophysical Research Communications, 200, 417422.DOI: 10.1006/bbrc.1994.1465
  • Lagier, R., Bouvier, C.A., Van Strijhem, N. (1980) Skeletal changes in congenital fibrinogen abnormalities. Skeletal Radiology, 5, 233239.
  • Lee, K.N., Tae, W.C., Jackson, K.W., Kwon, S.H., McKee, P.A. (1999) Characterization of wild-type and mutant α2-antiplasmins: fibrinolysis enhancement by reactive site mutant. Blood, 94, 164171.
  • Leebeek, F.W.G., Stibbe, J., Knot, E.A.R., Kluft, C., Gomes, M.J., Beudeker, M. (1988) Mild haemostatic problems associated with congenital heterozygous α2-antiplasmin deficiency. Thrombosis and Haemostasis, 59, 96100.
  • Lijnen, H.R., Okada, K., Matsuo, O., Collen, D., Dewerchin, M. (1999) Alpha 2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding. Blood, 93, 22742281.
  • Lijnen, H.R., Van Hoef, B., Dewerchin, M., Collen, D. (2000) Alpha2-antiplasmin gene deficiency in mice does not affect neointima formation after vascular injury. Arteriosclerosis Thrombosis and Vascular Biology, 20, 14881492.
  • Lind, B. & Thorsen, S. (1999) A novel missense mutation in the human plasmin inhibitor (α2-anti-plasmin) gene associated with a bleeding tendency. British Journal of Haematology, 107, 317322.
  • Mast, A.E., Stadanlick, J.E., Lockett, J.M., Dietzen, D.J. (1999) Solvent/detergent-treated plasma has decreased antitrypsin activity and absent antiplasmin activity. Blood, 94, 39223927.
  • Menoud, P.A., Sappino, N., Boudal-Khoshbeen, M., Vassalli, J.D., Sappino, A.P. (1996) The kidney is a major site of alpha 2-antiplasmin production. Journal of Clinical Investigation, 97, 24782484.
  • Miles, L.A., Plow, E.F., Donnelly, K.J., Hougie, C., Griffin, J.H. (1982) A bleeding disorder due to deficiency of alpha 2-antiplasmin. Blood, 59, 12461251.
  • Miura, O. & Aoki, N. (1990) Impaired secretion of mutant alpha 2-plasmin inhibitor (alpha 2-PI-Nara) from COS-7 and HepG2 cells: molecular and cellular basis for hereditary deficiency of α2-plasmin inhibitor. Blood, 75, 10921096.
  • Miura, O., Sugahara, Y., Nakamura, Y., Hirosawa, S., Aoki, N. (1989a) Restriction fragment length polymorphism caused by a deletion involving Alu sequences within the human alpha 2-plasmin inhibitor gene. Biochemistry, 28, 49344938.
  • Miura, O., Sugahara, Y., Aoki, N. (1989b) Hereditary alpha 2-plasmin inhibitor deficiency caused by a transport-deficient mutation (α2-PI-Okinawa): deletion of Glu137 by a trinucleotide deletion blocks intracellular transport. Journal of Biological Chemistry, 264, 1821318219.
  • Miura, O., Hirosawa, S., Kato, A., Aoki, N. (1989c) Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor: a frameshift mutation leading to elongation of the deduced amino acid sequence. Journal of Clinical Investigation, 83, 15981604.
  • Miyauchi, Y., Mii, Y., Aoki, M., Tamai, S., Takahashi, Y., Yoshioka, A. (1996) Operative treatment of intramedullary hematoma associated with congenital deficiency of alpha 2-plasmin inhibitor. A report of three cases. American Journal of Bone and Joint Surgery, 9, 14091414.
  • Moroi, M. & Aoki, N. (1976) Isolation and characterization of alpha 2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. Journal of Biological Chemistry, 251, 59565965.
  • Moroi, M. & Aoki, N. (1977) Inhibition of plasminogen binding to fibrin by alpha 2-plasmin inhibitor. Thrombosis Research, 10, 851856.
  • Mui, P.T.K., James, H.I., Ganguly, P. (1975) Isolation and properties of a low molecular weight anti-plasmin of human blood platelets and serum. British Journal of Haematology, 29, 627637.
  • Nichols, W.C., Amamo, K., Cacheris, P.M., Figuierido, M.S., Michaelides, K., Schwaab, R., Hoyer, L., Kaufman, R.J., Ginsberg, D. (1996) Moderation of hemophilia A phenotype by the factor V R506Q mutation. Blood, 88, 11831187.
  • Okada, K., Lijnen, H.R., Dewerchin, M., Belayew, A., Matsuo, O., Collen, D. (1997) Characterization and targeting of the murine α2-antiplasmin gene. Thrombosis and Haemostasis, 78, 11041110.
  • Plow, E.F. & Collen, D. (1981) The presence and release of alpha 2-antiplasmin from human platelets. Blood, 58, 10691074.
  • Rijken, D.C., Juhan-Vague, I., Collen, D. (1983) Complexes between tissue-type plasminogen activator and proteinase inhibitors in human plasma, identified with an immunoradiometric assay. Journal of Laboratory and Clinical Medicine, 101, 285294.
  • Robbie, L.A., Bennett, B., Keyt, B.A., Booth, N.A. (2000) Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha 2-antiplasmin. British Journal of Haematology, 111, 517523.DOI: 10.1046/j.1365-2141.2000.02365.x
  • Saito, H., Goodnough, L.T., Knowles, B.B., Aden, D.P. (1982) Synthesis and secretion of α2-plasmin inhibitor by established liver cells lines. Proceedings of the National Academy of Sciences of the United States of America, 79, 56845687.
  • Sakata, Y. & Aoki, N. (1980) Cross-linking of α2 plasmin inhibitor to fibrin by fibrin-stabilizing factor. Journal of Clinical Investigation, 65, 290297.
  • Sakata, Y. & Aoki, N. (1982) Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. Journal of Clinical Investigation, 69, 536542.
  • Sasaki, T., Morita, T., Iwanaga, S. (1986) Identification of the plasminogen-binding site of human alpha 2-plasmin inhibitor. Journal of Biochemistry, 99, 16991705.
  • Shahian, D.M. & Levine, J.D. (1990) Open-heart surgery in a patient with heterozygous α2-antiplasmin deficiency. Chest, 97, 14881490.
  • Stormorken, H., Gogstad, G.O., Brosstad, F. (1983) Hereditary alpha 2-antiplasmin deficiency. Thrombosis Research, 31, 647651.
  • Sumi, Y., Ichikawa, Y., Nakamura, Y., Miura, O., Aoki, N. (1989) Expression and characterization of pro alpha 2-plasmin inhibitor. Journal of Biochemistry, 106, 703707.
  • Takada, A. & Takada, Y. (1980) Interaction of plasmin with α2-macroglobulin and alpha2-antiplasmin in the presence and absence of tranexamic acid. Thrombosis Research, 59, 237246.
  • Takahashi, Y., Tanaka, T., Nakajima, N., Yoshioka, A., Fukui, H., Miyauchi, Y., Mii, Y., Tamai, S. (1991) Intramedullary multiple hematomas in siblings with congenital alpha 2-plasmin inhibitor deficiency: orthopedic surgery with protection by tranexamic acid. Haemostasis, 21, 321327.
  • Tamaki, T. & Aoki, N. (1982) Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. Journal of Biological Chemistry, 257, 1476714772.
  • Welch, S.K. & Francke, U. (1992) Assignment of the human alpha2-plasmin inhibitor gene (PLI) to chromosome 17, region pter-p12, by PCR analysis of somatic cell hybrids. Genomics, 13, 213214.
  • Wiman, B. & Collen, D. (1977) Purification and characterization of human antiplasmin, the fast-acting plasmin inhibitor in plasma. European Journal of Biochemistry, 78, 1926.
  • Wiman, B., Lijnen, H.R., Collen, D. (1979) On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha 2-antiplasmin and in fibrinogen. Biochimica Biophysica Acta, 579, 142154.
  • Yoshinaga, H., Hirosawa, S., Chong, D.H., Miyassaka, N., Aoki, N., Favier, R. (2000) A novel point mutation of the splicing donor site in the intron 2 of the α2-plasmin inhibitor gene. Thrombosis and Haemostasis, 84, 307311.
  • Yoshioka, A., Kamitsuji, H., Takase, T., Iida, Y., Tsukada, S., Mikami, S., Fukui, H. (1982) Congenital deficiency of alpha 2-plasmin inhibitor in three sisters. Haemostasis, 11, 176182.
  • Zarnovicanova, M. & Mocikova, K. (2000) A homozygous quantitative defect of alpha 2-antiplasmin in a family from central Slovakia. Bratislava Leukemia Listings, 101, 2830.